Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Rat (Rattus) Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Chicken Polyclonal PDE4D3 Primary Antibody pour CM, ICC - ABIN2750952
Bora, Malik, Arya, Gupta, Singh, Aggarwal, Dastidar, Ray, Saini: A reporter gene assay for screening of PDE4 subtype selective inhibitors. dans Biochemical and biophysical research communications 2007
Genetic analysis identified the identical, novel heterozygous missense mutation of the PDE4D (Montrer PDE4D Anticorps) gene c.569C>T (p.Ser190Phe) in two patients in same family. This case illustrates the significant phenotypic variability of acrodysostosis even within one family with identical mutations.
Screening of PRKAR1A (Montrer PRKAR1A Anticorps) and PDE4D (Montrer PDE4D Anticorps) in a Large Italian Series of Patients Clinically Diagnosed With Albright Hereditary Osteodystrophy and/or Pseudohypoparathyroidism
p53 (Montrer TP53 Anticorps) induced the transcription of miR (Montrer MLXIP Anticorps)-139-5p, which in turn suppressed the protein levels of phosphodiesterase 4D (Montrer PDE4D Anticorps) (PDE4D (Montrer PDE4D Anticorps)), an oncogenic protein involved in multiple tumor promoting processes.
High PDE4D (Montrer PDE4D Anticorps) expression is associated with melanoma.
cells on fibronectin (Montrer FN1 Anticorps) suppressed cAMP via enhanced phosphodiesterase (PDE (Montrer ALDH7A1 Anticorps)) activity, through direct binding of integrin alpha5 to phosphodiesterase-4D5
we performed a meta-analysis of 15 studies, involving 8731 IS patients and 10,756 controls. The results showed nonsignificant association between PDE4D (Montrer PDE4D Anticorps) SNP56 and IS risk (T vs. A: OR=1.01, 95%CI=0.88-1.15, P=0.90). Similarly, in the subgroup analysis by ethnicity, no significant association was observed in Asian (T vs. A: OR=1.08, 95%CI=0.80-1.44, P=0.62) or European (T vs. A: OR=0.96, 95%CI=0.86-1.08, P=0.54) population.
RACK1 (Montrer GNB2L1 Anticorps) and beta-arrestin2 (Montrer ARRB2 Anticorps) inhibit the dimerization of PDE4D5.
PDE4D (Montrer PDE4D Anticorps) acts to allow cAMP-elevating agents to regulate VECADs' role as a sensor of flow-associated fluid shear stress (FSS)-encoded information in arterial endothelial cells.
PDE4D (Montrer PDE4D Anticorps) gene polymorphisms influence the susceptibility for the development of Sudden Sensorineural Hearing Loss in the southern Taiwanese female population.
focus on recent progress made in PDE4D (Montrer PDE4D Anticorps) gene research involving genetic and molecular aspects (review)
This gene encodes one of four mammalian counterparts to the fruit fly 'dunce' gene. The encoded protein has 3',5'-cyclic-AMP phosphodiesterase activity and degrades cAMP, which acts as a signal transduction molecule in multiple cell types. This gene uses different promoters to generate multiple alternatively spliced transcript variants that encode functional proteins.
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
, cAMP-specific phosphodiesterase PDE4D6
, phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila)